Psychedelic treatments move closer to mainstream at FDA
Psychedelic drug treatments are gaining momentum at the federal level, prompting the Food and Drug Administration to solicit public input on the potential supervised therapeutic use of psychedelic drugs.
Original Source
Read the full article at Washingtontimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.